• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌合并间质性肺疾病患者的生存分析。

Survival analysis in lung cancer patients with interstitial lung disease.

机构信息

Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

出版信息

PLoS One. 2021 Sep 7;16(9):e0255375. doi: 10.1371/journal.pone.0255375. eCollection 2021.

DOI:10.1371/journal.pone.0255375
PMID:34492020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8423282/
Abstract

OBJECTIVE

Lung cancer patients with interstitial lung disease (ILD) are prone for higher morbidity and mortality and their treatment is challenging. The purpose of this study is to investigate whether the survival of lung cancer patients is affected by the presence of ILD documented on CT.

MATERIALS AND METHODS

146 patients with ILD at initial chest CT were retrospectively included in the study. 146 lung cancer controls without ILD were selected. Chest CTs were evaluated for the presence of pulmonary fibrosis which was classified in 4 categories. Presence and type of emphysema, extent of ILD and emphysema, location and histologic type of cancer, clinical staging and treatment were evaluated. Kaplan-Meier estimates and Cox regression models were used to assess survival probability and hazard of death of different groups. P value < 0.05 was considered significant.

RESULTS

5-year survival for the study group was 41% versus 48% for the control group (log-rank test p = 0.0092). No significant difference in survival rate was found between the four different categories of ILD (log-rank test, p = 0.195) and the different histologic types (log-rank test, p = 0.4005). A cox proportional hazard model was used including presence of ILD, clinical stage and age. The hazard of death among patients with ILD was 1.522 times that among patients without ILD (95%CI, p = 0.029).

CONCLUSION

Patients with lung cancer and CT evidence of ILD have a significantly shorter survival compared to patients with lung cancer only. Documenting the type and grading the severity of ILD in lung cancer patients will significantly contribute to their challenging management.

摘要

目的

患有间质性肺疾病(ILD)的肺癌患者发病率和死亡率较高,其治疗具有挑战性。本研究旨在探讨胸部 CT 上记录的ILD 是否会影响肺癌患者的生存。

材料与方法

回顾性纳入了 146 例初诊胸部 CT 显示ILD 的患者作为研究组,同时选择了 146 例无ILD 的肺癌对照患者。评估胸部 CT 上是否存在肺纤维化,并将其分为 4 类。评估肺气肿的存在和类型、ILD 和肺气肿的程度、癌症的位置和组织学类型、临床分期和治疗。使用 Kaplan-Meier 估计和 Cox 回归模型评估不同组的生存概率和死亡风险。P 值<0.05 被认为具有统计学意义。

结果

研究组的 5 年生存率为 41%,对照组为 48%(对数秩检验,P=0.0092)。ILD 的四个不同类别(对数秩检验,P=0.195)和不同的组织学类型(对数秩检验,P=0.4005)之间的生存率无显著差异。使用包括ILD、临床分期和年龄的 Cox 比例风险模型。ILD 患者的死亡风险是无ILD 患者的 1.522 倍(95%CI,P=0.029)。

结论

与仅患有肺癌的患者相比,胸部 CT 显示有ILD 的肺癌患者的生存率显著缩短。记录肺癌患者ILD 的类型和严重程度将对其具有挑战性的管理产生重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/c4a2ce88d328/pone.0255375.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/9f4f27d68d8f/pone.0255375.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/6aa6136125be/pone.0255375.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/86b29e97e466/pone.0255375.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/a2c97c35d3e2/pone.0255375.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/cd92c01008a9/pone.0255375.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/f16b89acd30e/pone.0255375.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/68db9e94b69a/pone.0255375.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/c4a2ce88d328/pone.0255375.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/9f4f27d68d8f/pone.0255375.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/6aa6136125be/pone.0255375.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/86b29e97e466/pone.0255375.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/a2c97c35d3e2/pone.0255375.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/cd92c01008a9/pone.0255375.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/f16b89acd30e/pone.0255375.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/68db9e94b69a/pone.0255375.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e218/8423282/c4a2ce88d328/pone.0255375.g008.jpg

相似文献

1
Survival analysis in lung cancer patients with interstitial lung disease.肺癌合并间质性肺疾病患者的生存分析。
PLoS One. 2021 Sep 7;16(9):e0255375. doi: 10.1371/journal.pone.0255375. eCollection 2021.
2
Deleterious impact of trivial to severe interstitial pneumonia and emphysema on mortality and acute exacerbation of interstitial pneumonia in patients with lung cancer: a retrospective cohort study.肺癌患者的轻度至重度间质性肺炎和肺气肿对死亡率和间质性肺炎急性加重的有害影响:一项回顾性队列研究。
BMC Pulm Med. 2024 Jun 22;24(1):290. doi: 10.1186/s12890-024-03105-7.
3
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).法国进行性纤维性间质性肺病的流行病学、死亡率和疾病负担评估(PROGRESS 研究)。
Respir Res. 2021 May 24;22(1):162. doi: 10.1186/s12931-021-01749-1.
4
Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer.有或无肺气肿的间质性肺炎对临床Ⅰ期肺癌患者的预后作用。
Jpn J Clin Oncol. 2021 Jul 1;51(7):1123-1131. doi: 10.1093/jjco/hyab073.
5
Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.肺叶切除术与亚肺叶切除术治疗特发性肺纤维化合并临床Ⅰ期非小细胞肺癌的结果。
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1089-1096.e1. doi: 10.1016/j.jtcvs.2017.03.116. Epub 2017 Apr 4.
6
Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.间质性肺疾病对非小细胞肺癌患者手术短期和长期生存的影响:危险因素分析。
Eur J Cardiothorac Surg. 2013 Jan;43(1):e17-23. doi: 10.1093/ejcts/ezs560. Epub 2012 Nov 4.
7
Impact of interstitial lung disease gender-age-physiology index in surgically treated lung cancer.间质肺病性别-年龄-生理学指数对肺癌手术治疗的影响。
Int J Clin Oncol. 2024 Oct;29(10):1475-1482. doi: 10.1007/s10147-024-02600-5. Epub 2024 Aug 24.
8
Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).纤维化性间质性肺炎可预测类风湿关节炎相关间质性肺病(RA-ILD)患者的生存情况。
Respir Med. 2013 Aug;107(8):1247-52. doi: 10.1016/j.rmed.2013.05.002. Epub 2013 Jun 19.
9
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis.系统性硬化症相关的肺纤维化合并肺气肿的总体死亡率。
RMD Open. 2019 Feb 14;5(1):e000820. doi: 10.1136/rmdopen-2018-000820. eCollection 2019.
10
Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.特发性胸膜肺弹力纤维增生症患者高分辨率 CT 下肺下叶间质病变的临床意义。
Respir Med. 2019 Jul-Aug;154:122-126. doi: 10.1016/j.rmed.2019.06.018. Epub 2019 Jun 20.

引用本文的文献

1
Analysis of baseline interstitial lung abnormality on the risk of checkpoint inhibitor-related pneumonitis and survival in advanced non-small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.分析一线PD-1/PD-L1抑制剂治疗的晚期非小细胞肺癌患者基线间质性肺异常与检查点抑制剂相关肺炎风险及生存情况的关系。
Transl Lung Cancer Res. 2025 Mar 31;14(3):912-930. doi: 10.21037/tlcr-2025-150. Epub 2025 Mar 20.
2
The value of fibrosis score and F-FDG by positron emission tomography-computed tomography in lung cancer patients with interstitial lung disease.肺癌合并间质性肺疾病患者的纤维化评分及正电子发射断层扫描-计算机断层扫描F-FDG的价值
J Thorac Dis. 2025 Mar 31;17(3):1541-1551. doi: 10.21037/jtd-24-1512. Epub 2025 Mar 10.
3

本文引用的文献

1
Interstitial Lung Disease Associated with Lung Cancer: A Case-Control Study.与肺癌相关的间质性肺疾病:一项病例对照研究。
J Clin Med. 2020 Mar 5;9(3):700. doi: 10.3390/jcm9030700.
2
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.特发性肺纤维化患者中的肺癌。希腊的一项回顾性多中心研究。
Pulm Pharmacol Ther. 2020 Feb;60:101880. doi: 10.1016/j.pupt.2019.101880. Epub 2019 Dec 23.
3
Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications.合并肺癌的间质性肺疾病:一种数据挖掘方法揭示了一种具有性别和免疫相关特定影响的复杂病症。
Front Oncol. 2024 Dec 17;14:1488157. doi: 10.3389/fonc.2024.1488157. eCollection 2024.
4
Lung Cancer and Interstitial Lung Diseases.肺癌与间质性肺疾病
Cancers (Basel). 2024 Aug 13;16(16):2837. doi: 10.3390/cancers16162837.
5
Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease.特发性肺纤维化合并肺癌患者的临床特征及预后。
BMC Pulm Med. 2024 Mar 15;24(1):136. doi: 10.1186/s12890-024-02946-6.
6
An Accelerated Failure Time Model to Predict Cause-Specific Survival and Prognostic Factors of Lung and Bronchus Cancer Patients with at Least Bone or Brain Metastases: Development and Internal Validation Using a SEER-Based Study.一种加速失效时间模型,用于预测至少有骨转移或脑转移的肺癌和支气管癌患者的特定病因生存率及预后因素:基于监测、流行病学和最终结果(SEER)研究的模型开发与内部验证
Cancers (Basel). 2024 Feb 4;16(3):668. doi: 10.3390/cancers16030668.
7
Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single-center, retrospective cohort study.间质性肺疾病合并肺癌患者急性加重的临床特征和预后影响:一项单中心回顾性队列研究。
Thorac Cancer. 2023 Nov;14(33):3323-3330. doi: 10.1111/1759-7714.15124. Epub 2023 Sep 29.
8
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer.免疫检查点抑制剂治疗非小细胞肺癌中 KL-6 的临床意义。
Cancer Chemother Pharmacol. 2023 Nov;92(5):381-390. doi: 10.1007/s00280-023-04573-0. Epub 2023 Aug 22.
9
Treating lung cancer in patients with interstitial lung disease: what do we know?治疗间质性肺疾病患者的肺癌:我们了解什么?
J Thorac Dis. 2023 Apr 28;15(4):1555-1558. doi: 10.21037/jtd-23-316. Epub 2023 Mar 30.
10
A nomogram for the prediction of the survival of patients with advanced non-small cell lung cancer and interstitial lung disease.晚期非小细胞肺癌合并间质性肺疾病患者生存预测列线图
Cancer Med. 2023 May;12(10):11375-11384. doi: 10.1002/cam4.5852. Epub 2023 Mar 31.
特发性肺纤维化和间质性肺疾病患者的肺癌特征——机构和人群数据分析。
Respir Res. 2018 Oct 3;19(1):195. doi: 10.1186/s12931-018-0899-4.
4
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
5
Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.特发性肺纤维化中的肺癌:系统评价和荟萃分析。
PLoS One. 2018 Aug 16;13(8):e0202360. doi: 10.1371/journal.pone.0202360. eCollection 2018.
6
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者肺癌的发病率及预测因素
ERJ Open Res. 2018 Feb 2;4(1). doi: 10.1183/23120541.00111-2016. eCollection 2018 Jan.
7
Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease.间质性肺疾病患者非小细胞肺癌完全切除术后的长期生存情况。
Interact Cardiovasc Thorac Surg. 2018 Apr 1;26(4):638-643. doi: 10.1093/icvts/ivx400.
8
Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis.特发性肺纤维化中肺癌的患病率、危险因素及生存率
Thorac Cancer. 2012 May;3(2):150-155. doi: 10.1111/j.1759-7714.2011.00107.x.
9
Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty.间质性肺疾病的肺活检:权衡手术风险与诊断不确定性
Eur Respir J. 2016 Nov;48(5):1274-1277. doi: 10.1183/13993003.01633-2016.
10
Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis.合并肺纤维化和肺气肿的肺癌:一项系统评价和荟萃分析
PLoS One. 2016 Sep 12;11(9):e0161437. doi: 10.1371/journal.pone.0161437. eCollection 2016.